B

Botswana Harvard AIDS Institute Partnership | Molepolole CRS

Research site

(Unclaimed)

Location

Private Bag BO320 Gaborone, Gaborone, Kweneng, Botswana

Site insights

Top conditions

Top treatments

Dolutegravir

Isoniazid

PAS

tenofovir

Delamanid

pretomanid

rilpivirine

Efavirenz

nevirapine

tenofovir alafenamide fumarate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 8 total trials

Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB

This study will evaluate the pharmacokinetics, safety, and tolerability of the anti-tuberculosis (TB) drug delamanid (DLM) in combination with an opt...

Active, not recruiting

Tuberculosis

HIV Infections

Drug: Delamanid

Drug: Optimized multidrug background regimen (OBR) for children with MDR-TB

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms